Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania

Mauricio Tohen; Eduard Vieta; Guy M. Goodwin; Bin Sun; Jay D. Amsterdam; Michael Banov; Anantha Shekhar; Scott T. Aaronson; L. M. Bardenstein; I Grecu-Gaboş; В А Точилов; Dan Prelipceanu; Heather S. Oliff; Ludmila Kryzhanovskaya; Charles L. Bowden

doi:10.4088/jcp.v69n1113

Related publications

Article2007

P.2.f.002 Olanzapine versus divalproex and placebo for the treatment of mild to moderate mania associated with bipolar I disorder

Mauricio Tohen, Eduard Vieta, Julia Amsterdam, Scott T. Aaronson, Bin Sun, Charles L. Bowden, Michael Banov, Anantha Shekhar, Heather S. Oliff, L. Kryzhanovskaya

Letter2003

Divalproex Versus Olanzapine in Mania

Eduard Vieta

Article2003

Olanzapine Versus Placebo in Acute Mania

Ross J. Baldessarini, John Hennen, Michael G. Wilson, Joseph R. Calabrese, Roy Chengappa, Paul E. Keck, Susan L. McElroy, Gary Sachs, Eduard Vieta, Jeffrey A. Welge, Lakshmi N. Yatham, Carlos A. Zarate, Robert W. Baker, Mauricio Tohen

Article2012

Risk Factors for Antidepressant-Related Switch to Mania

Marc Valentí, Isabella Pacchiarotti, Caterina del Mar Bonnín, Adriane Ribeiro Rosa, Dina Popović, Alessandra Nivoli, José Manuel Goikolea, Andréa Murru, Juan Undurraga, Francesc Colom, Eduard Vieta

Article2021

Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials

Christopher Em Griffiths, Marjolein de Bruin‐Weller, Mette Deleuran, Maria Concetta Fargnoli, D. Staumont‐Sallé, Chih-ho Hong, Jose Sánchez-Carazo, Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya Cyr, Ana B. Rossi